scan. Outcomes of interest were hypertension, proteinuria and kidney disease (CKD stages II-IV or ESRD). These 3 outcomes were also considered as a composite outcome. Kaplan-Meier survival curves were constructed and association of initial RS with event-free survival was analyzed using Log-Rank test.
INTRODUCTION AND OBJECTIVES: Hydronephrosis (HN)
without obstruction is a common finding in patients awaiting vesicoureteral reimplantation for high-grade vesicoureteral reflux (VUR). Though a common phenomenon, postoperative HN (POHN) still raises concern for some surgeons who fear the presence of silent obstruction. We aim to determine the natural progression and clinical significance of postoperative HN in children who have previously undergone open (OUR) or robot-assisted (RALUR) ureteral reimplantation for VUR.
METHODS: We retrospectively reviewed medical records of pediatric patients who underwent OUR or RALUR between December 2007 and December 2017. Baseline characteristics, operative outcomes, and trends in post-operative HN were then compared between OUR and RALUR.
RESULTS: In the 10-year study period, 129 patients met inclusion criteria. 52 (40.3%) patients underwent OUR and 77 (59.7%) patients underwent RALUR. POHN was identified in 21 (40%) of OUR and 21 (27%) of RALUR patients (P[0.1190). In patients with POHN, 15 (71%) OUR and 13 (62%) RALUR patients had no evidence of pre-operative HN. 38/42 (90.5%) of patients with POHN, who were managed by clinical observation, had spontaneous improvement with a mean time to resolution of 381 (AE 466) days. Mean time-to-resolution of POHN was 553 and 242 days for OUR and RALUR, respectively (P[0.0063). Of 3 patients in the OUR cohort with persistent POHN, 2 had persistent bilateral VUR and underwent redo OUR and 1 had isolated persistent bilateral HN. One patient in the RALUR cohort had persistent bilateral VUR and underwent redo OUR. Bilateral reimplantation was found to be an independent risk factor for both persistent HN and delayed recovery. Overall time-to-resolution of HN was significantly higher in this group compared to unilateral reimplantation (699 vs 216 days, P[0.0035). This finding was seen in both OUR (821 vs 314 days, P[0.0423) and RALUR (502 vs160 days, P[0.0187) groups.
CONCLUSIONS: HN following ureteral reimplantation is a common finding. POHN is frequently transient and benign. In most cases it resolves within one year after surgery, supporting the evidence that ureteral obstruction after reimplantation is a rare event. Patients with high-grade pre-operative bilateral VUR and HN requiring bilateral vesicoureteral reimplantation are at higher risk for developing more severe and prolonged POHN and should be closely monitored with imaging studies for resolution of their HN.
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MP64-16 IMPACT OF THE 2011 AMERICAN ACADEMY OF PEDIATRICS (AAP) URINARY TRACT INFECTION (UTI) GUIDELINE ON VESICOURETERAL REFLUX INDEX (VURX)
Aylin Bilgutay*, Michael Garcia-Roig, Courtney McCracken, Andrew Kirsch, Atlanta, GA INTRODUCTION AND OBJECTIVES: Vesicoureteral reflux (VUR) is a common cause of febrile urinary tract infections (fUTI) in children. The 2011 AAP UTI guidelines recommended a VCUG after the second fUTI or if anomalies are seen on renal/bladder ultrasound following the initial fUTI. The VURx estimates the likelihood of spontaneous VUR resolution based on gender, VUR timing/grade, and anatomic abnormalities. Higher VURx correlates with lower likelihood of spontaneous resolution (Fig. 1a) , and therefore more clinically significant VUR. We hypothesized the VURx score of new VUR diagnosis would increase after 2011, representing increased diagnosis of clinically significant VUR that is less likely to resolve spontaneously.
METHODS: VUR patients diagnosed from 2006-2014 were identified. Demographics, date of diagnosis, and VURx were collected. VURx was compared in patients diagnosed before and after 10/1/2011 to assess guideline impact.
RESULTS: We studied 661 children diagnosed between 1/2006 and 12/2014. There were 489 patients (mean 1.5 years old, 75% female) in the pre-guideline period, and 172 patients (mean 2.4 years old, 82% female) post-guideline. We found no significant difference in the mean, median, or distribution of VURx in children diagnosed before (3.25 AE 0.96) or after (Fig. 1b) . Vol. 201, No. 4S, Supplement, Sunday, May 5, 2019 THE JOURNAL OF UROLOGY Ò e947
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